Default company panoramic image
Logo

Glooko

Glooko transforms the way patients and their healthcare team interact and manage diabetes by leveraging the power of our mobile platform

  • Stage Full Product Ready
  • Industry Healthcare Services
  • Location Palo Alto, CA, USA
  • Currency USD
  • Founded July 2010
  • Employees 18
  • Website glooko.com

Company Summary

Glooko's 510(k) cleared solution starts by allowing patients to seamlessly transfer blood glucose data from all major glucose meters to a mobile application. Our application and cloud platform creates a "trusted" logbook and analytics that are leveraged by clinicians and health plan/disease management teams to more effectively engage patients and adjust care plans. This results in better diabetes manage and thus lower complications and costs.

Team

  • Default avatar
    Rick Altinger
    CEO

    Mr. Altinger has spent 20 years in the technology industry, concentrating on healthcare information technologies for the last 15 years. Prior to Glooko, he was a Vice President in the healthcare business unit of Intuit where he launched the healthcare division’s provider services and drove the effort that resulted in Intuit acquiring Medfusion for $91M in May 2010. Medfusion, now the core of Intuit Health, is the leading supplier of patient-prov

  • Default avatar
    Rita Sharma
    VP Marketing

    Ms. Sharma had worked in the healthcare industry for over 20 years, a majority of time committed to improving diabetes management with the power of technology. At LifeScan (Johnson & Johnson), she was a Director of Strategic Marketing where she led the development of strategy and innovative products in managing diabetes for both patients and professionals. She was responsible for accelerating LifeScan’s strategic shift from a blood glucose monito

  • Default avatar
    Dean Lucas
    VP Product Development

    Ms. Sharma had worked in the healthcare industry for over 20 years, a majority of time committed to improving diabetes management with the power of technology. At LifeScan (Johnson & Johnson), she was a Director of Strategic Marketing where she led the development of strategy and innovative products in managing diabetes for both patients and professionals. She was responsible for accelerating LifeScan’s strategic shift from a blood glucose monito

  • Default avatar
    Michael Greenfield, MD
    Chief Medical Officer

    Dr. Greenfield has been in diabetes healthcare, education, research, consultation, and advocacy for 30 years. Along with an active clinical practice in diabetes and endocrinology, Dr. Greenfield is Chairperson of the Institutional Review Board at El Camino Hospital, overseeing patient safety of clinical research conducted in and around the hospital. He currently serves on the Board of Directors of Pacific Partners Management Services, Inc. and

Advisors

  • Default avatar
    Gunderson Dettmer
    Lawyer
    Unconfirmed
    Default avatar
    Myoung Kang
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Chamath Palihapitiya, The Social+Capital Partnership (Will invest in next round)
    Unconfirmed
    Default avatar
    Yogen Dalal, Partner Emeritus, Mayfield Fund (Will invest in next round)
    Unconfirmed
    Default avatar
    Numerous angel investors: See https://www.glooko.com/about/
    Unconfirmed